Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wafer-level burn-in may be Aehr Test Systems’ technical edge, yet investors often just want to know who is buying stock, how margins move, or whether new EV design wins are material. That information is scattered across hundreds of pages and several form types—especially when you search for “Aehr Test Systems SEC filings explained simply.” The same hunt includes the “Aehr Test Systems quarterly earnings report 10-Q filing” and “Aehr Test Systems insider trading Form 4 transactions,” turning routine research into a time drain.
Stock Titan’s platform removes that friction. Our AI-powered summaries break down every section of the annual report—search “Aehr Test Systems annual report 10-K simplified” and jump straight to key risk factors. Receive real-time alerts for “Aehr Test Systems Form 4 insider transactions real-time,” so you see executive stock moves minutes after they hit EDGAR. New design-win announcements? We flag them the moment the company files an 8-K, giving you “Aehr Test Systems 8-K material events explained” in plain English.
Whether you’re comparing backlog growth across quarters or vetting “Aehr Test Systems executive stock transactions Form 4,” our coverage spans every disclosure type:
- AI-generated “Aehr Test Systems earnings report filing analysis” with side-by-side trend charts
- Guided walkthroughs for “understanding Aehr Test Systems SEC documents with AI”
- Red-lined changes in the preliminary “Aehr Test Systems proxy statement executive compensation” so pay packages are clear
No more digging through PDFs—our expert analysis, real-time updates, and full Form library put the critical data points in context, letting you act before the market does.
Aehr Test Systems reported an insider transaction by its Exec VP of Sales & Marketing. On 10/22/2025, the officer exercised options and acquired 110,283 and 185 shares of common stock at an exercise price of $2.03 per share (transaction code M).
Following these transactions, the officer reported 178,989 shares beneficially owned, held directly. The exercised options were from grants dated 11/23/2018 with expiration on 10/23/2025, and the remaining derivative balance for these grants is 0. A footnote states the reported amount includes shares subject to unvested restricted stock units.
Aehr Test Systems reported results of its October 20, 2025 annual meeting. Of 29,968,988 shares entitled to vote, 20,156,704 were represented in person or by proxy.
Shareholders elected six directors. They approved an amendment to the 2023 Equity Incentive Plan to add 2,500,000 shares and an amendment to the Employee Stock Purchase Plan to add 300,000 shares. The selection of BPM LLP as independent registered public accounting firm for the fiscal year ending May 29, 2026 was ratified. A non-binding advisory vote approved executive compensation. On frequency, shareholders supported holding the advisory vote on executive compensation every 1 year, and the Board determined to adopt an annual cadence. The next required advisory vote on frequency will occur no later than the 2031 Annual Meeting.
Aehr Test Systems (AEHR) Form 4: A company officer reported an automatic share withholding tied to RSU vesting on 10/20/2025. 336 shares of common stock were withheld at $24.76 to cover taxes (Transaction Code F), which is not a market sale. After the transaction, the officer reports 29,360 shares held directly and 5,214 held indirectly by a trust.
Aehr Test Systems reported an amended Form 4 for an officer (Exec. VP Sales and Marketing) to correct prior-day disclosures. The filing updates tax-withholding share counts tied to equity transactions and the resulting ownership totals.
Corrected figures: 502 shares were withheld at $25.52 on 10/13/2025 (Code F), and 403 shares were withheld at $27.29 on 10/14/2025 (Code F). Beneficial ownership after these transactions was corrected to 68,924 shares following the 10/13 entry and 68,521 shares following the 10/14 entry.
Aehr Test Systems (AEHR) filed a Form 4 for an officer. On 10/13/2025, 208 shares of common stock were withheld (transaction code F) at $23.49 per share to satisfy tax withholding upon the vesting of restricted stock units; this was not an open-market sale.
Following the transaction, the reporting person beneficially owned 29,696 shares directly and 5,214 shares indirectly by trust. The filer is listed as an officer (VP Contractor Business Unit) and filed individually.
Aehr Test Systems (AEHR) CFO Siu Chris filed a Form 4 reporting a tax withholding transaction tied to restricted stock units. On 10/13/2025, 695 shares of common stock were withheld at $23.49 per share under code F (shares withheld for taxes upon RSU vesting), which the filer states is not a sale.
Following the transaction, the reporting person beneficially owns 74,714 shares directly and 5,211 shares indirectly by trust.
AEHR Test Systems officer filed a Form 4 reporting tax withholdings tied to RSU vesting. On 10/13/2025, 1,399 shares were withheld at $25.52 (Code F). On 10/14/2025, 1,125 shares were withheld at $27.29 (Code F). The filing states these are to satisfy tax obligations and are not sales by the reporting person. Following these entries, the officer directly beneficially owned 66,902 shares, which includes shares subject to unvested RSUs.
Aehr Test Systems officer (CTO) filed a Form 4 reporting automatic share withholdings to cover taxes upon RSU vesting. On 10/13/2025, 422 shares were withheld at $25.52 per share (transaction code F). On 10/14/2025, 298 shares were withheld at $27.29 per share (code F). The filing notes these entries do not represent sales by the reporting person.
Following these transactions, the officer reported beneficial ownership of 214,620 shares, which includes shares subject to unvested restricted stock units.
AEHR Test Systems reported insider transactions by its President and CEO/Director. On 10/13/2025 and 10/14/2025, the reporting person had F-code share withholdings to cover taxes upon vesting of equity awards: 3,791 shares at $25.52 and 3,448 shares at $27.29. The filer notes this does not represent a sale.
Following these transactions, beneficial ownership stood at 261,914 shares direct and 291,628 shares indirect by Trust. The direct amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
AEHR Test Systems reported an insider transaction by its Chief Operating Officer on a Form 4. On 10/13/2025, 385 shares of common stock were withheld at $25.52 under transaction code F to satisfy tax withholding obligations upon vesting of restricted stock units; this was not a sale by the reporting person.
Following the transaction, the officer beneficially owned 46,926 shares directly. The reported holdings include shares subject to unvested restricted stock units.
FAQ
What is the current stock price of Aehr Test Sys (AEHR)?
What is the market cap of Aehr Test Sys (AEHR)?
